Eyelid Dermatitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-11-12
Clinical Trial Update: Upadacitinib As a Novel Treatment for Refractory Eyelid Dermatitis [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating upadacitinib as a potential treatment for refractory eyelid dermatitis. The study is not yet recruiti…